Page 69 - DEDU506_SPECIAL_EDUCATION_ENGLISH
P. 69

Unit 9: Visually Impaired: Preventions and Teaching Strategies


                directed treatment with ivermectin and the SAFE strategy for trachoma control, and their  Notes
                adoption by Member States and international partners. This unified approach facilitated
                preventive efforts aimed at millions of individuals at risk of visual loss, and convinced major
                donors that long-term commitment is required.
                Subsequently, major shifts in the pattern of causes of blindness have been documented, with a
                declining trend for the communicable causes and a progressive increase in age-related chronic
                eye conditions. Public health interventions for some of the major conditions such as cataract
                and diabetic retinopathy have been systematically reviewed and respective WHO
                recommendations have been formulated. Strategies are needed to control other conditions such
                as glaucoma.
                By October 2008, 150 Member States have held national or subnational VISION 2020 workshops
                to introduce WHO’s strategies for eye health. These workshops were the platform for sharing
                expertise about community eye health and facilitated the process of needs assessment and
                subsequent formulation of national and subnational blindness-prevention plans.
            (iv) Prevention of avoidable blindness and visual impairment as a global health issue: Reliable
                epidemiological data and the availability of cost-effective interventions for the control of most
                of the major causes of avoidable blindness have demonstrated the importance of strengthening
                national initiatives in preserving eye health. In resolutions WHA56.26 and WHA59.25, the Health
                Assembly recommended a unified approach to blindness-prevention activities, urging Member
                States to establish national committees, to set up national blindness-prevention plans, and to
                devise strong monitoring and evaluation mechanisms for their implementation. In addition, it
                has been recognized that advocacy for preventing visual loss needs to reach a wider audience,
                and that the importance of preserving eye health needs to be further promoted in the public
                health domain and the community.
                In some countries the impact of Health Assembly resolutions on allocation of new resources for
                development and implementation of blindness-prevention plans has fallen short of expectations.
                In most countries action is slow and progress in implementing adequate blindness-prevention
                activities is limited.
                Plans and programmes on blindness prevention exist at global level and in some cases at regional
                level, but action is now required to provide support to Member States in applying international
                experience and scientific evidence in order to develop and implement their own blindness-
                prevention measures. Further action is required to integrate the eye-health agenda and its impact
                on poverty alleviation in the overall development agenda.
            (v)  International partnerships: Over the past decade, major international partnerships have been
                forged to assist WHO in providing support to Member States in their efforts to prevent blindness,
                such as “VISION 2020: the Right to Sight”. The partnerships have made substantial progress,
                mostly in combating infectious causes of blindness. They have also encouraged and supported
                long-term resource mobilization, including donation programmes (e.g. the Merck donation
                programme for ivermectin to control onchocerciasis, and distribution of azithromycin under a
                donation programme by Pfizer to control trachoma). Global partnerships have united and
                substantially strengthened the key international stakeholders in their action to prevent blindness,
                using WHO disease control strategies.
                Coordination and timely evaluation of work undertaken by international partners is required
                so that their approaches are aligned with other activities in the area of blindness prevention.
                Despite some notable improvements in collecting data on blindness-prevention activities at the
                country and subnational levels, consolidated reporting remains limited. One reason is the
                weakness of many countries’ monitoring systems, another being the limited information sharing
                and exchange between countries and their international partners.
                The action now required is to improve coordination and information exchange between all
                stakeholders.





                                               LOVELY PROFESSIONAL UNIVERSITY                                     63
   64   65   66   67   68   69   70   71   72   73   74